The current commercial research and development model is failing to keep up with the pace of infectious diseases. Three out of every seven people around the world are at risk of contracting a major infectious disease, and one in seven people are already infected.
Global health groups working to combat diseases such as tuberculosis, malaria, HIV and AIDS and neglected tropical diseases are calling for new ways of developing lifesaving vaccines, treatments and diagnostics. Partnerships between public and private bodies are increasingly seen as the answer, because they can be cheaper, faster and are unmotivated by profit.
But how can global development professionals and organizations forge such partnerships, and what does it take to ensure success?
About the author
Gabriella Jóźwiak@GabriellaJ
Gabriella Jóźwiak is an award-winning journalist based in London. Her work on issues and policies affecting children and young people in developing countries and the U.K. has been published in national newspapers and magazines. Having worked in-house for domestic and international development charities, Jóźwiak has a keen interest in organizational development, and has worked as a journalist in several countries across West Africa and South America.
